Bezac, tablets 40 mg 50 pcs

Parkinson’s disease, SeizuresParkinson’s disease, Parkinson’s syndrome (as part of combined therapy), extrapyramidal disorders caused by antipsychotics (neuroleptics).

Indications

Parkinson’s disease, parkinsonism syndrome (as part of combination therapy), extrapyramidal disorders caused by antipsychotics (neuroleptics).

Pharmacological effect

Antiparkinsonian drug.

Special instructions

Use with caution in patients with epilepsy, arrhythmia, and elderly patients.

Drug dependence may develop.

Treatment should be discontinued gradually due to the risk of withdrawal symptoms.

The safety of biperiden in children has not been established, so its use is not recommended.

During the treatment period, avoid drinking alcohol.

Impact on the ability to drive vehicles and operate machinery

Use with caution in patients whose activities require increased attention and speed of psychomotor reactions.

Elderly

Use with caution in elderly patients.

Active ingredient

Biperiden

Composition

1 tab. – biperiden hydrochloride 2 mg.

Pregnancy

The use of biperiden during pregnancy and lactation (breastfeeding) is possible only under strict indications.

Contraindications

Angle-closure glaucoma, prostatic hyperplasia, obstructive conditions of the gastrointestinal tract (including pyloric stenosis, paralytic ileus), megacolon; hypersensitivity to biperiden.

Side Effects

From the side of the central nervous system: weakness, asthenia, dizziness, stupor, anxiety, memory impairment, confusion, hallucinations.

From the organ of vision: mydriasis, disturbance of accommodation.

From the cardiovascular system: tachycardia; rarely – bradycardia; with parenteral administration – a decrease in blood pressure.

From the digestive system: dry mouth, dyspepsia, constipation.

Metabolism: decreased sweating.

From the urinary system: in patients with prostatic hypertrophy – difficulty urinating.

Allergic reactions: skin rash, itching.

Interaction

When used simultaneously with anticholinergic drugs, it is possible to enhance the central and peripheral anticholinergic effects.

When used simultaneously with antipsychotics (neuroleptics), the risk of developing tardive dyskinesia increases.

When used simultaneously with biperiden, the effect of histamine H1 receptor blockers and anticonvulsants is enhanced.

When used simultaneously with levodopa, an increase in the m-anticholinergic effect and dyskinesia is possible.

With simultaneous use, biperiden reduces the effectiveness of metoclopramide.

When used simultaneously with quinidine, the risk of developing dyskinesia increases. Potentiates the effect of ethanol.

Storage conditions

Store in a place protected from light, out of reach of children at temperatures up to 30 °C.

Shelf life

3 years.

Manufacturer

Obninsk HFC, Russia